Duties of the Research Committee Sample Clauses

Duties of the Research Committee. The Research Committee shall direct and administer the Research Programs. With respect to the Research Programs, the Solvay Duphar representatives on the Research Committee shall, in consultation with the ArQule representatives, determine the identity, scope and priority of each Chemical Theme. The identity and scope of such Chemical Theme will be determined on the basis of the following criteria: (i) the specific reaction or reaction sequence used to combine members of two or more discrete chemical units in which each chemical unit bears the functional group(s) required for the specific reaction(s) that result in the combination of the chemical units; and (ii) the extent to which a class of compounds is related by a recurring structural motif associated with a particular biological activity. With respect to the SA Program, the Research Committee shall specifically determine the following: (i) the appropriate number and type of Chemical Themes represented in the Arrays delivered to Solvay Duphar each Contract Year; (ii) the appropriate number of compounds for each Chemical Theme in the Arrays delivered to Solvay Duphar each Contract Year; and (iii) the appropriate amount of each compound to be provided for a particular Chemical Theme. With respect to the DA Program, the Research Committee shall specifically determine the following: (i) the appropriate number and type of Chemical Themes for submission to the DA Program, subject to ArQule's right to exclude certain compounds as set forth in Section 2.3 below; (ii) the appropriate number of compounds that ArQule should generate in a Directed Array for a particular Chemical Theme; and (iii) the appropriate amount of each compound in a Directed Array that ArQule should deliver to Solvay Duphar for further research and development. In * confidential treatment has been requested for marked portions addition, the Research Committee shall (i) determine the allocation of the funding and personnel resources to be contributed by the parties under this Agreement, (ii) revise and extend the Research Plan each calendar quarter for the subsequent six (6) months based on prior developments, (iii) resolve matters involving scientific questions, and (iv) resolve publication disputes that may arise under Section 10.4.
Sample 1See All (4)
AutoNDA by SimpleDocs
Duties of the Research Committee. The Research Committee shall direct and administer the Research Program in general accordance with the following provisions:
Sample 1Sample 2
Duties of the Research Committee. The Research Committee shall direct and administer the screening undertaken pursuant to this Agreement. The Research Committee shall review test reports provided by Scriptgen [***]
Sample 1Sample 2
Duties of the Research Committee. The Research Committee shall direct and administer the Research Program. With respect to each Directed Array(TM) Program, the Research Committee shall specifically determine the following: (i) the appropriate objectives of each Chemical Theme and/or Active Compound to be submitted to the Directed Array(TM) Program; (ii) the appropriate number and type of Chemical Themes to be submitted to the Directed Array(TM) Program, subject to ArQule's right to exclude certain compounds as set forth in Section 3.2.3 below; (iii) the appropriate number of compounds that ArQule should generate in a Directed
Sample 1Sample 2
Duties of the Research Committee. The Research Committee shall direct and administer the Research Program. Specifically, the Research Committee shall develop and revise the Research Plan. In addition, the Research Committee shall (i) designate Active Compounds as Licensed Compounds as described in Section 3.6.; (ii) maintain and update the list of Licensed Compounds; (iii) determine the allocation of the funding and personnel resources to be contributed by ArQule for each Directed Array Program; and (iv) resolve matters involving scientific questions.
Sample 1
Duties of the Research Committee. The Research Committee shall direct and administer the research activities under this Agreement. The Research Committee shall (i) review test reports provided by Monsanto as to the significant functional activity derived from testing the ArQule Compounds to confirm that ArQule Compounds are Active Compounds in accordance with Section 3.2.2, (ii) confirm whether ArQule Compounds that are Active Compounds and any Active Homologs selected by Monsanto are properly designated as a Licensed Compounds in accordance with the procedures set forth in Section 3.2.2; (iii) maintain and update the list of Licensed Compounds; and (iv) resolve matters involving scientific questions and any operational issues that may arise in the research activities under this Agreement.
Sample 1

Related to Duties of the Research Committee

  • Research Committee 2.2.1 Establishment and Functions of the RC. -------------------------------------

  • Joint Research Committee The Parties hereby establish a committee to facilitate the Research Program as follows:

  • Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).

  • Advisory Committee (a) The Partnership shall have a committee (the “Advisory Committee”) consisting of Fund Investors or their representatives or designees selected by the Managing General Partner; provided that no member of the Advisory Committee shall be an Affiliate of the Managing General Partner (or a designee or representative thereof). The Managing General Partner will meet with the Advisory Committee at least semi-annually to consult on various matters concerning the Partnership, including financial statements and appraisals, the status of existing investments and such other matters as the Managing General Partner may determine or any member of the Advisory Committee may reasonably propose.

  • Duties of Directors Except as provided in this Agreement, in exercising their rights and performing their duties under this Agreement, the Directors shall have a fiduciary duty of loyalty and care similar to that of a director of a business corporation organized under the General Corporation Law of the State of Delaware.

  • Rights and Duties of the Board of Managers (a) The Company is a manager-managed limited liability company. Accordingly, management of the affairs of the Company shall be vested in a Board of Managers (the “Board”). The Persons constituting the Board (each, a “Manager”) will be (i) the “managers” of the Company for all purposes under the Act and (ii) the Board for all purposes under this Agreement. The Board will have the power to act only by a majority of the Managers in accordance with the provisions and in the manner specified herein. A person does not need to be a Member to serve on the Board. The Board will initially consist of three members and shall initially consist of, Nxxxx Xxxxxxx, Jxxx Xxxxxxxxx and Exx Xxxxxxxxx as the Independent Manager, who shall serve until they resign or are replaced by a majority of the Board, and new members of the Board shall be appointed by a majority of the Board. Provided, however, the Members holding 66 2/3% of the Voting Shares can vote to remove and replace a Manager for “Cause” in accordance with Section 2.9. The size of the Board may be increased, including, without limitation, in connection with forming a Special Committee, or decreased from time to time by action of the Board.

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Steering Committee Each Party shall name a mutually agreed upon equal number of representatives for the Steering Committee, which shall meet twice per calendar year, or as otherwise mutually agreed by the Parties. In the event that a Steering Committee dispute cannot be resolved, such dispute shall be escalated to a senior executive of each of Customer and Lonza. The primary function of the Steering Committee is to ensure the ongoing communication between the Parties and discuss and resolve any issues arising under this Agreement. In addition to the primary function described above, the Steering Committee shall also take on the following responsibilities:

  • Duties of the Fund (a) Each Fund shall furnish to the Distributor copies of all information, financial statements and other papers which the Distributor may reasonably request for use in connection with the distribution of its Shares, including one certified copy, upon request by the Distributor, of all financial statements prepared by the Fund and examined by independent accountants. Each Fund shall, at the expense of the Distributor, make available to the Distributor such number of copies of its Prospectus as the Distributor shall reasonably request.

  • Duties of the Parties JHU is not a commercial organization. It is an institute of research and education. Therefore, JHU has no ability to evaluate the commercial potential of any PATENT RIGHTS or LICENSED PRODUCT or other license or rights granted in this Agreement. It is therefore incumbent upon Company to evaluate the rights and products in question, to examine the materials and information provided by JHU, and to determine for itself the validity of any PATENT RIGHTS, its freedom to operate, and the value of any LICENSED PRODUCTS or SERVICES or other rights granted.

Time is Money Join Law Insider Premium to draft better contracts faster.